-
2024-520210-21-00
5
2025-09-19
Crohn’s Disease
-
2025-520740-16-00
5
2025-09-19
Primary Aldosteronism defined by excess aldosterone secretion
-
2024-517633-40-00
5
2025-09-18
Hidradenitis Suppurativa
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-514030-20-00
4
2025-08-29
colorectal cancer
-
2024-518276-32-00
4
2025-08-29
Locally advanced and unresectable Stage III non-small cell lung cancer
-
2023-505109-17-00
5
2025-08-27
Sickle cell disease
-
2024-515875-36-00
4
2025-08-18
Advanced biliary tract cancer (BTC)
-
2024-515431-30-00
5
2025-08-14
Men treated with proctectomy for rectal cancer
-
2024-515577-10-00
6
2025-07-24
Kidney transplant
-
2024-515787-31-00
5
2025-07-18
Patient with early triple-negative breast cancer (TNBC) achieving path
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2023-508132-65-00
4
2025-06-30
NEUROENDOCRINE CELLS HYPERPLASIA OF INFANCY
-
2023-504831-42-00
5
2025-06-27
patient with colorectal cancer with hepatic metastasis
-
2023-510262-27-00
4
2025-06-24
newly diagnosed or relapsing deep venous thrombosis related to Behçet’
-
2024-512412-22-00
5
2025-06-24
Hemolytic Uremic Syndrome
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2023-509788-25-00
6
2025-06-16
Rheumatoid arthritis
-
2024-519991-18-00
6
2025-06-16
Rheumatoid Arthritis
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-517335-46-00
4
2025-06-05
Bladder cancer
-
2023-506935-14-01
5
2025-06-01
Ischemic stroke
-
2024-516605-23-00
5
2025-05-12
relapsed/refractory nodal T cell lymphoma with T follicular helper (TF
-
2023-507519-36-00
5
2025-04-29
Acne